Cubist Systematic Strategies’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History

Cubist Systematic Strategies’s Portfolio THRX Stock Details THRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-18,588	Closed	-$75.3K	–	4437
2023 Q4	$75.3K	Buy	+18,588	New	+$56.7K	﹤0.01%	3225
2023 Q2	–	Sell	-18,081	Closed	-$161K	–	4515
2023 Q1	$161K	Buy	+18,081	New	+$177K	﹤0.01%	3314

Cubist Systematic Strategies's THRX Position: Q1 2024 in Review

Cubist Systematic Strategies sold out of Theseus Pharmaceuticals, Inc. Common Stock (THRX) in Q1 2024, closing a stake of 18,588 shares — an estimated $75.3K sold.

Cubist Systematic Strategies first reported a position in THRX in Q1 2023 and held it in 2 quarters. The position peaked at $161K in Q1 2023. 1 fund tracked by Wall St. Rank holds THRX as of Q1 2024.

Cubist Systematic Strategies reported no remaining Theseus Pharmaceuticals, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Cubist Systematic Strategies sold 18,588 Theseus Pharmaceuticals, Inc. Common Stock shares in Q1 2024, an estimated $75.3K.
Cubist Systematic Strategies first reported a position in Theseus Pharmaceuticals, Inc. Common Stock in Q1 2023 and held it in 2 quarters.
Cubist Systematic Strategies's Theseus Pharmaceuticals, Inc. Common Stock position peaked at $161K in Q1 2023.
1 fund tracked by Wall St. Rank held Theseus Pharmaceuticals, Inc. Common Stock as of Q1 2024.

Based on Cubist Systematic Strategies's 13F filing for Q1 2024, filed 15 May 2024.